Published 1992 | ISBN 1 87226 335 6 | Archived
The value of any screening programme will be diminished if appropriate action is not always taken on the tests with abnormal results. However, samples may be taken in many different situations by many different sample takers. This general statement of responsibility therefore needs to be backed up by failsafe systems to ensure that communication of results has occurred and follow up action has been taken.
Despite every endeavour some women will inevitably escape follow up, either because they consciously refuse to have further investigation or because they cannot be traced. Therefore guidelines are needed to define the point when all reasonable action has been taken and the attempts to follow up can cease. These guidelines are examples of good practice and individual purchasers and providers of cervical cytology screening services may choose to modify them according to local circumstances. These guidelines only refer to follow up of women with abnormal samples and not of those with inadequate or negative results.
- NHSCSP home page
- Programme publications
- About cervical screening
- Human Papilloma Virus (HPV)
- Research in cervical screening
- More information about the
screening programme- Information about cervical cancer
- Diethylstilbestrol (DES) exposed women
- Liquid Based Cytology (LBC)
- LBC implementation guidance
- Who does what in the programme
- Quality Assurance
- Use of patient information
- Cervical cytology training centres
- Human Papilloma virus (HPV)
- HPV triage and test of cure protocol
- HMR101 Request/Report Form
- 14 day turnaround time
- Frequently asked questions
- Programme statistics
- Programme news index
- Useful links